These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
159 related items for PubMed ID: 8374044
1. Mechanism-based inactivation of cytochrome P450 2B1 by 2-ethynylnaphthalene: identification of an active-site peptide. Roberts ES, Hopkins NE, Alworth WL, Hollenberg PF. Chem Res Toxicol; 1993; 6(4):470-9. PubMed ID: 8374044 [Abstract] [Full Text] [Related]
2. Identification of active-site peptides from 3H-labeled 2-ethynylnaphthalene-inactivated P450 2B1 and 2B4 using amino acid sequencing and mass spectrometry. Roberts ES, Hopkins NE, Zaluzec EJ, Gage DA, Alworth WL, Hollenberg PF. Biochemistry; 1994 Mar 29; 33(12):3766-71. PubMed ID: 8142377 [Abstract] [Full Text] [Related]
3. Mechanism-based inactivation of cytochrome P450 2B1 by 9-ethynylphenanthrene. Roberts ES, Hopkins NE, Zaluzec EJ, Gage DA, Alworth WL, Hollenberg PF. Arch Biochem Biophys; 1995 Nov 10; 323(2):295-302. PubMed ID: 7487091 [Abstract] [Full Text] [Related]
4. Inactivation of cytochrome P450 2B1 by benzyl isothiocyanate, a chemopreventative agent from cruciferous vegetables. Goosen TC, Kent UM, Brand L, Hollenberg PF. Chem Res Toxicol; 2000 Dec 10; 13(12):1349-59. PubMed ID: 11123978 [Abstract] [Full Text] [Related]
5. Mechanism-based inactivation of cytochromes P450 2B1 and P450 2B6 by 2-phenyl-2-(1-piperidinyl)propane. Chun J, Kent UM, Moss RM, Sayre LM, Hollenberg PF. Drug Metab Dispos; 2000 Aug 10; 28(8):905-11. PubMed ID: 10901699 [Abstract] [Full Text] [Related]
6. Identification of the heme adduct and an active site peptide modified during mechanism-based inactivation of rat liver cytochrome P450 2B1 by secobarbital. He K, Falick AM, Chen B, Nilsson F, Correia MA. Chem Res Toxicol; 1996 Aug 10; 9(3):614-22. PubMed ID: 8728507 [Abstract] [Full Text] [Related]
7. Inactivation of cytochrome P450s 2B1, 2B4, 2B6, and 2B11 by arylalkynes. Roberts ES, Hopkins NE, Foroozesh M, Alworth WL, Halpert JR, Hollenberg PF. Drug Metab Dispos; 1997 Nov 10; 25(11):1242-8. PubMed ID: 9351899 [Abstract] [Full Text] [Related]
8. Effect of 17-alpha-ethynylestradiol on activities of cytochrome P450 2B (P450 2B) enzymes: characterization of inactivation of P450s 2B1 and 2B6 and identification of metabolites. Kent UM, Mills DE, Rajnarayanan RV, Alworth WL, Hollenberg PF. J Pharmacol Exp Ther; 2002 Feb 10; 300(2):549-58. PubMed ID: 11805216 [Abstract] [Full Text] [Related]
10. A role for threonine 302 in the mechanism-based inactivation of P450 2B4 by 2-ethynylnaphthalene. Roberts ES, Pernecky SJ, Alworth WL, Hollenberg PF. Arch Biochem Biophys; 1996 Jul 15; 331(2):170-6. PubMed ID: 8660695 [Abstract] [Full Text] [Related]
11. Peroxynitrite-mediated nitration of tyrosine and inactivation of the catalytic activity of cytochrome P450 2B1. Roberts ES, Lin Hl, Crowley JR, Vuletich JL, Osawa Y, Hollenberg PF. Chem Res Toxicol; 1998 Sep 15; 11(9):1067-74. PubMed ID: 9760281 [Abstract] [Full Text] [Related]
12. The functional role of threonine-205 in the mechanism-based inactivation of P450 2B1 by two ethynyl substrates: the importance of the F helix in catalysis. Lin HL, Kent UM, Zhang H, Waskell L, Hollenberg PF. J Pharmacol Exp Ther; 2004 Dec 15; 311(3):855-63. PubMed ID: 15302894 [Abstract] [Full Text] [Related]
13. Modification of cytochrome P450 1A2 enzymes by the mechanism-based inactivator 2-ethynylnaphthalene and the photoaffinity label 4-azidobiphenyl. Yun CH, Hammons GJ, Jones G, Martin MV, Hopkins NE, Alworth WL, Guengerich FP. Biochemistry; 1992 Nov 03; 31(43):10556-63. PubMed ID: 1420171 [Abstract] [Full Text] [Related]
14. Aryl acetylenes as mechanism-based inhibitors of cytochrome P450-dependent monooxygenase enzymes. Foroozesh M, Primrose G, Guo Z, Bell LC, Alworth WL, Guengerich FP. Chem Res Toxicol; 1997 Jan 03; 10(1):91-102. PubMed ID: 9074808 [Abstract] [Full Text] [Related]
15. Mechanism-based inactivation of cytochromes P450 2B1 and P450 2B6 by n-propylxanthate. Kent UM, Yanev S, Hollenberg PF. Chem Res Toxicol; 1999 Apr 03; 12(4):317-22. PubMed ID: 10207119 [Abstract] [Full Text] [Related]
16. Mechanism-based inactivation of cytochrome P-450-3A4 by mifepristone (RU486). He K, Woolf TF, Hollenberg PF. J Pharmacol Exp Ther; 1999 Feb 03; 288(2):791-7. PubMed ID: 9918590 [Abstract] [Full Text] [Related]
17. Suicide inhibitors of cytochrome P450 1A1 and P450 2B1. Hopkins NE, Foroozesh MK, Alworth WL. Biochem Pharmacol; 1992 Aug 18; 44(4):787-96. PubMed ID: 1510726 [Abstract] [Full Text] [Related]
18. Cumene hydroperoxide-mediated inactivation of cytochrome P450 2B1. Identification of an active site heme-modified peptide. Yao K, Falick AM, Patel N, Correia MA. J Biol Chem; 1993 Jan 05; 268(1):59-65. PubMed ID: 8416964 [Abstract] [Full Text] [Related]
19. Mechanism-based inactivation of cytochrome P450 2B1 by N-benzyl-1-aminobenzotriazole. Kent UM, Bend JR, Chamberlin BA, Gage DA, Hollenberg PF. Chem Res Toxicol; 1997 May 05; 10(5):600-8. PubMed ID: 9168259 [Abstract] [Full Text] [Related]
20. Mechanism-based inactivation of cytochrome P450 3A4 by 17 alpha-ethynylestradiol: evidence for heme destruction and covalent binding to protein. Lin HL, Kent UM, Hollenberg PF. J Pharmacol Exp Ther; 2002 Apr 05; 301(1):160-7. PubMed ID: 11907170 [Abstract] [Full Text] [Related] Page: [Next] [New Search]